z-logo
Premium
Dose dependence and temporal evolution of the T 1 relaxation time and MRI contrast in the rat brain after subcutaneous injection of manganese chloride
Author(s) -
Shazeeb Mohammed Salman,
Sotak Christopher H.
Publication year - 2012
Publication title -
magnetic resonance in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.696
H-Index - 225
eISSN - 1522-2594
pISSN - 0740-3194
DOI - 10.1002/mrm.24184
Subject(s) - choroid plexus , in vivo , mri contrast agent , manganese , subcutaneous injection , magnetic resonance imaging , contrast (vision) , chemistry , pharmacokinetics , medicine , nuclear magnetic resonance , nuclear medicine , pharmacology , central nervous system , radiology , biology , artificial intelligence , computer science , physics , microbiology and biotechnology , organic chemistry
Divalent manganese ion (Mn 2+ ) is a widely used T 1 contrast agent in manganese‐enhanced MRI studies to visualize functional neural tracts and anatomy in the brain in vivo. In animal studies, Mn 2+ is administered at a dose that will maximize the contrast, while minimizing its toxic effects. In rodents, systemic administration of Mn 2+ via intravenous injection has been shown to create unique MRI contrast in the brain at a maximum dose of 175 mg kg −1 . However, intravenous administration of Mn 2+ results in faster bioelimination of excess Mn 2+ from the plasma due to a steep concentration gradient between plasma and bile. By contrast, following subcutaneous injection (LD 50 value = 320 mg kg −1 ), Mn 2+ is released slowly into the bloodstream, thus avoiding immediate hepatic elimination resulting in prolonged accumulation of Mn 2+ in the brain via the choroid plexus than that obtained via intravenous administration. The goal of this study was to investigate MRI dose response of Mn 2+ in rat brain following subcutaneous administration of Mn 2+ . Dose dependence and temporal dynamics of Mn 2+ after subcutaneous injection can prove useful for longitudinal in vivo studies that require brain enhancement to persist for a long period of time to visualize neuroarchitecture like in neurodegenerative disease studies. Magn Reson Med, 2012. © 2012 Wiley Periodicals, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom